Location History:
- Shimshon, IL (2005)
- Seattle, WA (US) (2005 - 2023)
Company Filing History:
2 out of 894 
2 out of 2,117 
1 out of 69 
Years Active: 2005-2023
Title: Nina Isoherranen: Innovator in Male Contraception and Retinoic Acid Metabolism
Introduction
Nina Isoherranen is a prominent inventor based in Seattle, WA, known for her significant contributions to the fields of male contraception and retinoic acid metabolism. With a total of 4 patents, her work has the potential to impact various therapeutic areas.
Latest Patents
Isoherranen's latest patents include innovative compounds aimed at male contraception. One of her notable inventions involves pyrazole and piperazine compounds that act as inhibitors of ALDH1A1 and ALDH1A2. These compounds are designed for use in male contraceptive compositions to prevent spermatogenesis. Additionally, she has developed specific inhibitors of cytochrome P450 26, which are directed towards treating diseases that benefit from the inhibition of CYP26 mediated retinoic acid metabolism. The compositions she has created comprise complex chemical structures that offer promising therapeutic applications.
Career Highlights
Throughout her career, Isoherranen has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the University of Washington. Her research has garnered attention for its innovative approach to addressing significant health issues.
Collaborations
Nina has collaborated with notable professionals in her field, including Meir Bialer and Boris Yagen. These partnerships have contributed to the advancement of her research and the development of her patented inventions.
Conclusion
Nina Isoherranen's work exemplifies the intersection of innovation and practical application in the medical field. Her contributions to male contraception and retinoic acid metabolism highlight her role as a leading inventor in these critical areas.